Register

I agree with the Privacy Policy

Los Angeles Times

Medical giant Medtronic to buy rival Covidien for $42.9 billion

June 15, 2014

Because both companies already are giants in the medical-devices market, the merger should allow for more robust research and development and more comprehensive health-monitoring capabilities, said Harry Wang, a health industry analyst at product research firm Parks Associates.

The medical devices industry has been plagued by slow innovation, but the merger should advance the market, Wang said.

“By buying up this company and consolidating R&D spending, they have a better chance of getting their products to market,” he said. “Over the long term, if R&D is spent wisely and effectively, you will see more cost-effective products for consumers.”

From the article, "Medical giant Medtronic to buy rival Covidien for $42.9 billion" by Javier Panzar.

Previously In The News

Blu-ray gets no victory parade

Some analysts caution against reading too much into the NPD figures, pointing out that the first quarter usually is not a crucial selling period for consumer electronics. "It's too early to tel...

Sony to launch online video service for PlayStation 3

"They've got to get a win in the digital, and I'd say on the electronic delivery side of the business," said Kurt Scherf, an analyst with Parks Associates who studies technology in the home. "That'...

More TV viewers may be cutting the cord this year

Nonetheless, Internet TVs began gathering retail momentum this year, as 1 in 4 high-definition televisions sold in the U.S. provided Internet capability, according to researcher Parks Associates. F...

For advertisers, they're not just games

Spending on ads in games is expected to grow 33% a year for the next five years, compared with just 3% for television advertising, according to Parks Associates. Part of that growth has to do with...

‹
1
2
3
4
5
6
7
8
9
10
›